Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study (2018)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s1474-4422(18)30054-1
PubMed Identifier: 29525492
Publication URI: http://europepmc.org/abstract/MED/29525492
Type: Journal Article/Review
Parent Publication: The Lancet Neurology
Issue: 5
ISSN: 1474-4422